Results 111 to 120 of about 17,300 (202)

Therapy of high blood pressure with bisoprolol preparations [PDF]

Bisoprolol is a beta-blocker commonly used in clinical practice, particularly valued for its high selectivity for beta-1 adrenergic receptors, with minimal impact on beta-2 receptors. It is frequently prescribed for the management of tachyarrhythmias and
Pęksa, Jan W.
core  

AQbD-assisted Hptlc Method for Simultaneous Determination of Bisoprolol Fumarate and Perindopril Arginine: Optimization, Validation and Comprehensive Sustainability Assessment [PDF]

Ratna Musale, Dewoo Patil, H. B. Mehta, Prexa Tandel   +3 more
openalex   +1 more source

Comparative real-world safety profiles of selective β1-adrenergic receptor blockers: A multi-database pharmacovigilance disproportionality study. [PDF]

Medicine (Baltimore)
Ren W, Zhao H, Wang Z, Li J, Niu Z, Zhou R, Cui Z, Zhang Z, Wang P.   +8 more
europepmc   +1 more source

Formulation Design and Development of Orodispersible Tablets of Bisoprolol Fumarate by Using Natural Superdisintegrants

Abid Hussain, Rajesh Asija, Priyam Shrivastava, Seema Yadav Trimukhe   +3 more
openalex   +1 more source

Cardiovascular Adverse Event Reporting Patterns for Atenolol, Bisoprolol, and Nebivolol: A Pharmacovigilance Disproportionality Analysis of the FDA Adverse Event Reporting System

Matthew Nho, Vinay Kumar, Hema Vathy, Ravi Prakash, Ahmed Abdel‐Latif, Anand Prakash Singh   +5 more
openalex   +1 more source

RP-HPLC Method Development and Validation of Bisoprolol Fumarate and Hydrochlorothiazide in Combined Dosage Forms.

Harshitha K B, Bhaskar Dr. S. Vijaya, Kavana M., Atanu Giri, Nithyasri, L Nargund 5Dr. Sachindra, L Nargund Dr. Shravan   +6 more
openalex   +1 more source

Quality Assessment of In-House Prepared Pediatric Oral Suspensions of Bisoprolol and Lisinopril: Assay and Dose Uniformity

Carmen-Maria Rusz, George Jîtcă, Lénárd Farczádi, Silvia Imre   +3 more
openalex   +1 more source

Eficácia e tolerabilidade da associação bisoprolol/hidroclorotiazida na hipertensão arterial

, 2017
PURPOSE: Multicenter, open and non-controlled study to evaluated the efficacy and the tolerability of a low-dose combination of two anti-hypertensive agents: a cardioselective beta-blocker, bisoprolol (2.5 and 5.0mg) with 6.25mg of hydrochlorothiazide ...
Raineri, Angela Maria de O., Maia, Lilia Nigro, Rocha, Joao Carlos da, Ramirez, Jose Antonio, Mion, Decio, God, Epotamenides Maria Good, Ortega, Katia Coelho, Luna, Rafael Leite, Batlouni, Michel, Chaves-Junior, Hilton de Castro, Castro, Iran, Feitosa, Gilson Soares, Oigman, Wille   +12 more
core  

Persistent Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Metoprolol: Resolution via Beta-blocker Switch. [PDF]

Acta Derm Venereol
Schricker T, Möhlenkamp N, Hübner F, Raap U, Patsinakidis N.   +4 more
europepmc   +1 more source

Method Development, Optimization And Validation For Simultaneous Estimation Of Dapagliflozin And Bisoprolol In Active Pharmaceutical Ingredient And Pharmaceutical Dosage Form By RP-HPLC Method

V. Amritha1*, D. Jothieswari2, B. Swarupa3
openalex   +1 more source